| Q35711283 | A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes |
| Q34233328 | Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics |
| Q37380362 | Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis |
| Q40309503 | Albuminuria in Rheumatoid Arthritis: Associations with RA Characteristics and Subclinical Atherosclerosis |
| Q40005980 | Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis. |
| Q37721221 | Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature. |
| Q36554649 | Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis |
| Q39783377 | Association of Rheumatoid Factors With Subclinical and Clinical Atherosclerosis in African American Women: The Multiethnic Study of Atherosclerosis. |
| Q33717110 | Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease |
| Q37445635 | Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease |
| Q36291358 | Association of vitamin D with cardiometabolic risk factors in rheumatoid arthritis |
| Q52372999 | Atherosclerotic vascular disease in the autoimmune rheumatologic woman. |
| Q92104941 | Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis |
| Q38230867 | Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis |
| Q48110781 | Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy |
| Q37859676 | Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity |
| Q28085227 | Causes of changes in carotid intima-media thickness: a literature review |
| Q37246482 | Coronary Artery Calcification Is Related to Inflammation in Rheumatoid Arthritis: A Long-Term Follow-Up Study |
| Q40556371 | Coronary Artery Calcification and Rheumatoid Arthritis: Lack of Relationship to Risk Alleles for Coronary Artery Disease in the General Population |
| Q36468887 | Coronary calcification in SLE: comparison with the Multi-Ethnic Study of Atherosclerosis |
| Q41482717 | Differential Association of Psychosocial Comorbidities With Subclinical Atherosclerosis in Rheumatoid Arthritis |
| Q57178937 | Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months |
| Q37521891 | ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis |
| Q50925168 | Endogenous bone morphogenetic protein 2 plays a role in vascular smooth muscle cell calcification induced by interleukin 6 in vitro. |
| Q52312175 | Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. |
| Q36058974 | Increased prevalence of subclinical atherosclerosis in rheumatoid arthritis patients of Indian descent. |
| Q35108734 | Indicators of walking speed in rheumatoid arthritis: relative influence of articular, psychosocial, and body composition characteristics |
| Q53035221 | Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis. |
| Q35656020 | Lack of association of oral calcium supplementation with coronary artery calcification in rheumatoid arthritis |
| Q48576327 | Left ventricular function at two-year follow-up in treatment-naive rheumatoid arthritis patients is associated with anti-cyclic citrullinated peptide antibody status: a cohort study. |
| Q34433298 | Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging |
| Q35489690 | Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis |
| Q38125279 | Molecular biology of atherosclerosis |
| Q36464831 | Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes |
| Q38098935 | Novel risk factors for cardiovascular disease in rheumatoid arthritis |
| Q36511541 | Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis |
| Q39378053 | Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease |
| Q37690404 | Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis |
| Q38794852 | Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity? |
| Q41617609 | Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study |
| Q38919261 | Role of Coronary Calcium for Risk Stratification and Prognostication |
| Q35981104 | Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis |
| Q47395275 | TNF Antagonists: Killing Two "Birds" with one Biologic "Stone". |
| Q47878182 | Ten-year progression of coronary artery, carotid artery, and aortic calcification in patients with rheumatoid arthritis. |
| Q35204645 | The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores |
| Q30537972 | Ultrasound common carotid artery segmentation based on active shape model |
| Q89647402 | Utility of Coronary Calcium Scoring (CCS) in Connective Tissue Disorders (CTDs) for the Evaluation of Subclinical Coronary Atherosclerosis - A Systematic Review |
| Q34164481 | Validated methods for assessment of subclinical atherosclerosis in rheumatology |
| Q35954706 | Vascular calcifications on hand radiographs in rheumatoid arthritis and associations with autoantibodies, cardiovascular risk factors and mortality |
| Q37630351 | Vascular effects of biologic agents in RA and spondyloarthropathies |
| Q53316049 | [Rheumatoid arthritis: subclinical atherosclerosis of the coronary arteries--effect of age, sex and disease activity]. |